Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
47,820,954
-
Share change
-
+125,184
-
Total reported value
-
$1,084,574,647
-
Put/Call ratio
-
24%
-
Price per share
-
$22.68
-
Number of holders
-
83
-
Value change
-
+$2,240,117
-
Number of buys
-
38
-
Number of sells
-
37
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2018
As of 30 Jun 2018,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,820,954 shares.
The largest 10 holders included
Woodford Investment Management Ltd, BAUPOST GROUP LLC/MA, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, ARMISTICE CAPITAL, LLC, STATE STREET CORP, and NORGES BANK.
This page lists
83
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.